A Breath of Hope Lung Foundation’s executive director, Nancy Torrison met with Vice President Biden and his senior adviser Don Graves, U.S. Representative Rick Nolan and a small group of Minnesota cancer leaders to discuss the Cancer Moonshot 2020. With stage 4 lung cancer patient, Katherine Bensen, present to share her real-life story, the two women had an amazing opportunity to state and emphasize the often-obscured facts about lung cancer to the group.
CDI (Center for Diagnostic Imaging), partner of ABOH and sponsor of the Twin Cities Lung Run/Walk, met with Executive Director Nancy Torrison to discuss the importance of the low-dose CT scan. The low-dose CT scan is a non-invasive scan that can detect lung cancer and if used will reduce the 82.5% mortality rate. Low-dose CT scans are available to people who have a smoking history – one pack a day for thirty years or two packs a day for fifteen years. To learn more about CDI and the low-dose CT scan, click here.
A lung nodule may sound scary, but it’s really a fancy word for a “spot in the lung,” says University of Minnesota Health Thoracic Surgeon Rafael Andrade, MD. They are often caused by a small growth in the lung, or a reaction of the lung to inflammation or infection. They are frequently identified with an X-ray or CT scan.
A Breath of Hope Lung Foundation is proud to announce our 2014 Research Fellowships in support of two talented young investigators focused on creating careers in lung cancer research. The RFP invited researchers in their first five years of their first faculty appointment to apply for two-year $150,000 awards. The awards represent A Breath of Hope Lung Foundation’s efforts to retain talent in the work being done to find effective new treatments and an eventual cure for America’s deadliest cancer – Lung Cancer.
Abbie Begnaud, Pulmonologist (MD) and Asst Professor of Medicine, University of Minnesota.
The Lung Cancer Screening program at the University of Minnesota is a comprehensive, patient-centered program offering participation in active research and assistance with smoking cessation. Like many programs, our accessibility is limited by lack of uniform insurance coverage. We have a competitive out-of-pocket price ($99) for all eligible patients. But unlike other programs, the University of Minnesota screening program is the only in the state of Minnesota designated a center of excellence by the Lung Cancer Alliance. Centers of Excellence provide evidence-based care with a multidisciplinary approach, including participation in ongoing research as well as smoking cessation tools for current smokers. Our dedicated thoracic oncology group consists of pulmonologists, oncologists, radiologists, surgeons and nurses who devote themselves to lung and thoracic cancers.
After years of debate, Medicare has not yet decided whether it should cover lung cancer screening, yet if there is any doubt that the stig-ma is alive and well, just Google Medicare Lung Cancer and read on. While Americans argue about whether preventative screenings should be allowed to increase Medicare costs, 160,000 Americans (2500 Minnesotans) will die of the disease this year. At the time of diagno-sis, more than half had quit smoking or never smoked at all. We don’t question preventative screening for other cancers that are also affect-ed by smoking, nor do we question the billions of dollars spent on other diseases, such as diabetes and heart disease that can also be caused or exacerbated by unhealthy personal choices. How is this fair? How do we justify dismissing the cancer that claims more American lives than any other cancer?
The Charities Review Council’s Accountability Standards® are co-created benchmarks of nonprofit governance, finance, fundraising, and public communication. A balance of nonprofit sector promising practices, public expectations, and legal/regulatory requirements, the standards represent the shared expectations between donors and nonprofits.